Evidence map›Paper›PMID 39741388›Full record

ArticleAging cell2025

Identifying ENO1 as a protein target of chlorogenic acid to inhibit cellular senescence and prevent skin photoaging in mice.

Xueling He, Chen Wang, Qianyu Zhang, Tong Yang, Qiuyan Guo, Yaxu Wang, Jiayue Guo, Pengjie Wang, Junzhe Zhang, Huan Tang and 2 more

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. HIF1AJournal for immunotherapy of cancer · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Polyphenol-Rich Extracts fromAntioxidants (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xueling HeState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Chen WangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Qianyu ZhangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Tong YangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Qiuyan GuoState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Yaxu WangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Jiayue GuoBeijing Advanced Innovation Center for Food Nutrition and Human Health, Department of Nutrition and Health, China Agricultural University, Beijing, China.
Pengjie WangBeijing Advanced Innovation Center for Food Nutrition and Human Health, Department of Nutrition and Health, China Agricultural University, Beijing, China.
Junzhe ZhangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Huan TangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
Yinhua ZhuBeijing Advanced Innovation Center for Food Nutrition and Human Health, Department of Nutrition and Health, China Agricultural University, Beijing, China.ORCID 0009-0002-2803-3579
Jigang WangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Funding

Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ14-YQ-061Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ16-ND-10-16Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ16-ND-10-24Fundamental Research Funds for the Central Public Welfare Research Institutes ZZ17-ND-10-15Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine ZYYCXTD-C-202002National Key Research and Development Program of China 2020YFA0908000National Natural Science Foundation of China 32201177National Natural Science Foundation of China 82074098National Natural Science Foundation of China 82141001Scientific and Technological Innovation Project of the China Academy of the Chinese Medical Sciences CI2021B014Scientific and Technological Innovation Project of the China Academy of the Chinese Medical Sciences CI2023D003Scientific and Technological Innovation Project of the China Academy of the Chinese Medical Sciences CI2023E002-Y-30Scientific and Technological Innovation Project of the China Academy of the Chinese Medical Sciences CI2023E005TS01Scientific and Technological Innovation Project of the China Academy of the Chinese Medical Sciences ZG2024001-05Shenzhen Medical Research Fund of Shenzhen Medical Academy of Research and Translation B2302051
6 · The paper itself

Abstract

Cellular senescence plays a critical role in repeated ultraviolet (UV) exposure-induced skin photoaging. Currently, from the perspective of regulating senescent cells, potent compounds or reliable protein targets that could effectively prevent skin photoaging have not yet been reported. Herein, we demonstrated that chlorogenic acid (CGA) significantly inhibited UVA-induced senescence of human dermis skin fibroblasts (HDF) cells by screening the natural product library. The activity-based protein profiling (ABPP) result revealed that Enolase 1 (ENO1) is one of the direct targets of CGA in HDF cells. Further mechanism research indicated that CGA covalently binds to ENO1, and prevented UVA-induced cellular senescence by suppressing the activity of ENO1 protein to block the glycolytic pathway. Importantly, we found that CGA dose-dependently reduced the skin wrinkle score, alleviated skin pathological features and inhibited senescent characteristics in a photoaging mouse model. The proteomic analysis revealed that CGA treatment effectively inhibited senescence-associated secretory phenotype (SASP) secretion and glycolysis in skin samples of mice. Collectively, our study not only demonstrated that inhibiting cell senescence is an effective anti-skin photoaging strategy, but also revealed that ENO1 is a promising protein target to prevent photoaging.

Indexed as

Cellular SenescenceChlorogenic AcidDNA-Binding ProteinsPhosphopyruvate HydrataseSkin AgingTumor Suppressor ProteinsAnimalsBiomarkers, TumorFibroblastsHumansMiceSkinUltraviolet RaysBiomarkers, TumorChlorogenic AcidDNA-Binding ProteinsENO1 protein, humanEno1 protein, mousePhosphopyruvate HydrataseTumor Suppressor Proteinsactivity‐based protein profilingchlorogenic acidenolase 1glycolysisphotoaging

Identifiers

PMID39741388
PMCPMC11984691

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.